Kura Oncology Inc’s recently made public that its Director Hasnain Faheem unloaded Company’s shares for reported $0.18 million on Mar 21 ’25. In the deal valued at $8.00 per share,22,682 shares were sold. As a result of this transaction, Hasnain Faheem now holds 23,983 shares worth roughly $0.15 million.
Then, FAHEEM HASNAIN bought 30,000 shares, generating $235,500 in total proceeds.
Before that, DOYLE THOMAS JAMES sold 4,949 shares. Kura Oncology Inc shares valued at $38,958 were divested by the SVP, Finance & Accounting at a price of $7.87 per share. As a result of the transaction, DOYLE THOMAS JAMES now holds 88,193 shares, worth roughly $0.56 million.
BTIG Research downgraded its Kura Oncology Inc [KURA] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Stifel also remained covering KURA and has decreased its forecast on October 14, 2024 with a “Hold” recommendation from previously “Buy” rating. Mizuho started covering the stock on December 22, 2023. It rated KURA as “a Buy”.
Price Performance Review of KURA
On Tuesday, Kura Oncology Inc [NASDAQ:KURA] saw its stock fall -3.33% to $6.38. Over the last five days, the stock has lost -10.39%. Kura Oncology Inc shares have fallen nearly -26.75% since the year began. Nevertheless, the stocks have fallen -70.09% over the past one year. While a 52-week high of $23.48 was reached on 02/05/25, a 52-week low of $6.43 was recorded on 04/01/25. SMA at 50 days reached $7.77, while 200 days put it at $14.60.
Levels Of Support And Resistance For KURA Stock
The 24-hour chart illustrates a support level at 6.24, which if violated will result in even more drops to 6.10. On the upside, there is a resistance level at 6.55. A further resistance level may holdings at 6.72. The Relative Strength Index (RSI) on the 14-day chart is 30.98, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.54, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.79%. Stochastics %K at 12.43% indicates the stock is a buying.
How much short interest is there in Kura Oncology Inc?
A steep rise in short interest was recorded in Kura Oncology Inc stocks on 2025-03-14, dropping by -0.23 million shares to a total of 9.02 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 9.25 million shares. There was a decline of -2.52%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 11, 2023 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $31 price target.
